Efinaconazole
Efinaconazole Uses, Dosage, Side Effects, Food Interaction and all others data.
Efinaconazole is a 14 alpha-demethylase inhibitor indicated in the treatment of fungal infection of the nail, known as onychomycosis. It was approved for use in Canada and the USA in 2014 and is marketed by Valeant Pharmaceuticals North America LLC under the name Jublia.
mean ± SD plasma Cmax on Day 28 of treatment: 0.67 ± 0.37 ng/mL.mean ± SD AUC was 12.15 ± 6.91 ng*h/mL.
Trade Name | Efinaconazole |
Generic | Efinaconazole |
Efinaconazole Other Names | efinaconazol, Efinaconazole |
Weight | 10% |
Type | Topical Application, Topical Solution |
Formula | C18H22F2N4O |
Weight | Average: 348.398 Monoisotopic: 348.17616767 |
Groups | Approved |
Therapeutic Class | |
Manufacturer | |
Available Country | United States |
Last Updated: | September 19, 2023 at 7:00 am |
Uses
Efinaconazole is an antifungal agent used to treat onychomycosis, a fungal infection of the nail.
Indicated in the treatment of fungal infection of the nail, known as onychomycosis.
Efinaconazole is also used to associated treatment for these conditions: Onychomycosis
How Efinaconazole works
Efinaconazole is an azole antifungal. Efinaconazole inhibits fungal lanosterol 14α-demethylase involved in the biosynthesis of ergosterol, a constituent of fungal cell membranes.
Food Interaction
No interactions found.Half Life
29.9 hours in healthy patients.
Innovators Monograph
You find simplified version here Efinaconazole